Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Auricular Vagus Nerve Stimulation on Pain and Symptoms in Primary Dysmenorrhea

NCT: NCT07683637 · COMPLETED

NCT IDNCT07683637
StatusCOMPLETED
Start Date2023-06-01
Completion2024-03-05
SponsorIstanbul Gelisim University (OTHER)
First posted
Last updated

Brief Summary

This study aims to investigate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on menstrual pain, pain threshold, depression, anxiety, menstrual symptoms, premenstrual syndrome, and functional and emotional impact of dysmenorrhea in young adult women with primary dysmenorrhea.

Frequently Asked Questions

What is Effect of Auricular Vagus Nerve Stimulation on Pain and Symptoms in Primary Dysmenorrhea?

Effect of Auricular Vagus Nerve Stimulation on Pain and Symptoms in Primary Dysmenorrhea is a clinical trial registered under NCT07683637. Current status: COMPLETED.

What is the status of NCT07683637?

The current status of NCT07683637 (Effect of Auricular Vagus Nerve Stimulation on Pain and Symptoms in Primary Dysmenorrhea) is: COMPLETED.

When did Effect of Auricular Vagus Nerve Stimulation on Pain and Symptoms in Primary Dysmenorrhea start?

Effect of Auricular Vagus Nerve Stimulation on Pain and Symptoms in Primary Dysmenorrhea started on 2023-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.